These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
30. Flow cytometric enumeration of CD34+ hematopoietic stem and progenitor cells in leukapheresis product and bone marrow for clinical transplantation: a comparison of three methods. Gajkowska A; Oldak T; Jastrzewska M; Machaj EK; Walewski J; Kraszewska E; Pojda Z Folia Histochem Cytobiol; 2006; 44(1):53-60. PubMed ID: 16584093 [TBL] [Abstract][Full Text] [Related]
31. Surface antigen expression on CD34+ cord blood cells: comparative analysis by flow cytometry and limiting dilution (LD) RT-PCR of chymopapain-treated or untreated cells. Ziegler BL; Thoma SJ; Lamping CP; Valtieri M; Müller R; Samoggia P; Bühring HJ; Peschle C; Fliedner TM Cytometry; 1996 Sep; 25(1):46-57. PubMed ID: 8875054 [TBL] [Abstract][Full Text] [Related]
32. Anti-L-NGFR and -CD34 monoclonal antibodies identify multipotent mesenchymal stem cells in human adipose tissue. Quirici N; Scavullo C; de Girolamo L; Lopa S; Arrigoni E; Deliliers GL; Brini AT Stem Cells Dev; 2010 Jun; 19(6):915-25. PubMed ID: 19929314 [TBL] [Abstract][Full Text] [Related]
33. CD34+/CD90+ cells infused best predict late haematopoietic reconstitution following autologous peripheral blood stem cell transplantation. Sumikuma T; Shimazaki C; Inaba T; Ochiai N; Okano A; Hatsuse M; Ashihara E; Nakagawa M Br J Haematol; 2002 Apr; 117(1):238-44. PubMed ID: 11918561 [TBL] [Abstract][Full Text] [Related]
34. Extent of variability inherent in measurements of CD34-positive cells in different human haemopoietic tissues. Titley I; Healy LE; Scott M; Amos TA; Gordon MY Bone Marrow Transplant; 1995 Oct; 16(4):611-6. PubMed ID: 8528180 [TBL] [Abstract][Full Text] [Related]
35. CD34 molecule epitope distribution on cells of haematopoietic origin. Steen R; Egeland T Leuk Lymphoma; 1998 Jun; 30(1-2):23-30. PubMed ID: 9669673 [TBL] [Abstract][Full Text] [Related]
36. The phenotypic profile of CD34-positive peripheral blood stem cells in different mobilization regimens. de Boer F; Dräger AM; Van Haperen MJ; van der Wall E; Kessler F; Huijgens PC; Pinedo HM; Schuurhuis GJ Br J Haematol; 2000 Dec; 111(4):1138-44. PubMed ID: 11167753 [TBL] [Abstract][Full Text] [Related]
37. A novel mAb against a human CD34 peptide reacts with the native protein on CD34+ cells. Shams M; Jeddi-Tehrani M; Notash Haghighat F; Bayat AA; Mahmoudian J; Rezvani MR Iran J Immunol; 2013 Dec; 10(4):259-66. PubMed ID: 24375067 [TBL] [Abstract][Full Text] [Related]
38. Human monoclonal antibody directed against an envelope glycoprotein of human T-cell leukemia virus type I. Matsushita S; Robert-Guroff M; Trepel J; Cossman J; Mitsuya H; Broder S Proc Natl Acad Sci U S A; 1986 Apr; 83(8):2672-6. PubMed ID: 2422659 [TBL] [Abstract][Full Text] [Related]
39. The monoclonal antibody W7C5 defines a novel surface antigen on hematopoietic stem cells. Giesert C; Almeida-Porada G; Scheffold A; Kanz L; Zanjani ED; Bühring HJ Ann N Y Acad Sci; 2001 Jun; 938():175-83. PubMed ID: 11458505 [TBL] [Abstract][Full Text] [Related]
40. [Early stages of CD34+ differentiation during radiation exposure]. Bieliaieva NV Lik Sprava; 2006 Jun; (4):20-6. PubMed ID: 17100234 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]